Rb-82 Generator Quality Control

Q: What are the Sr-82 and Sr-85 breakthrough limits?

Under NRC regulation 10 CFR 35.204, a Rb-82 chloride injection must contain no more than 0.02 microcurie of Sr-82 per millicurie of Rb-82 and no more than 0.2 microcurie of Sr-85 per millicurie of Rb-82. Eluate that exceeds either limit must not be administered to patients, and a measurement that exceeds the limits must be reported.

Q: How often must strontium breakthrough be measured?

10 CFR 35.204 requires the licensee to measure the Sr-82 and Sr-85 concentration in the eluate before the first patient use of each day the generator is used. The FDA-approved generator labeling also requires additional testing once an alert limit is reached, and the record of each test must be retained as required by 10 CFR 35.2204.

Q: What happens if breakthrough exceeds the limit?

The eluate must not be administered to patients, the generator use must stop pending investigation, the measurement must be recorded, and the exceedance must be reported to the NRC or Agreement State as required. The facility should follow the manufacturer's instructions, involve the radiation safety officer and authorized user, and determine root cause before resuming clinical use.

Rb-82 generator quality control is the daily strontium-breakthrough test — together with elution technique, dose calibration, and recordkeeping — that keeps a strontium-82/rubidium-82 generator safe to use for cardiac PET. The generator's value is that it delivers rubidium-82, a 75-second myocardial perfusion tracer, on demand and without a cyclotron. Its hazard is that the parent isotope holding the column, strontium-82, is long-lived and can wash into the patient dose if the column degrades or is eluted incorrectly.¹⁷

Because the eluate is injected directly into patients, the U.S. Nuclear Regulatory Commission sets hard limits on how much strontium may be present, and requires that they be checked before the first patient of every day.¹ This guide explains the generator physics, the breakthrough test and its worked math, the two FDA-approved systems, the incidents that shaped current requirements, and the regulatory framework. DRPS supports these programs through its PET/CT and nuclear medicine physics and radiation safety officer services.

Introduction

A Sr-82/Rb-82 generator is a shielded column that continuously breeds a short-lived PET tracer from a long-lived parent. Strontium-82 (physical half-life about 25.4 days) is fixed on the column; it decays to rubidium-82 (physical half-life about 75 seconds), which is washed off — eluted — with saline and infused into the patient for myocardial perfusion PET.⁷⁸

That arrangement is what makes rubidium-82 clinically practical. A 75-second half-life would be impossible to ship or store, but a generator with a roughly one-to-two-month useful life regenerates its Rb-82 within minutes of each elution, enabling back-to-back rest and pharmacologic-stress perfusion studies in a busy cardiac PET lab.²⁹

The same design creates the central safety problem. If any strontium comes off the column with the rubidium — "breakthrough" — the patient receives a long-lived internal contaminant instead of a tracer that vanishes in minutes. Strontium is a bone-seeker, so even small breakthrough activities can deliver disproportionate committed dose. Rb-82 generator QC exists to detect and prevent that. For the clinical imaging side, see rubidium-82 cardiac PET myocardial perfusion imaging.

Topic Explanation

The parent, the daughter, and the contaminant

Three radionuclides matter for QC:

Rb-82 — the wanted product. A potassium analog taken up by viable myocardium; half-life about 75 seconds; positron emitter used for PET.⁷⁸
Sr-82 — the parent held on the column; half-life about 25.4 days; decays by electron capture to Rb-82. Breakthrough of Sr-82 is the primary safety concern because it is long-lived and a bone-seeker.⁷
Sr-85 — a contaminant co-produced with Sr-82 during cyclotron manufacture; half-life about 65 days; a gamma emitter. It is limited separately because it tracks strontium behavior and adds dose.¹⁷

The generator is manufactured with a known Sr-82 activity and a specified Sr-85/Sr-82 ratio. As the generator ages, Sr-82 decays with its 25.4-day half-life, so Rb-82 yield falls; meanwhile column integrity can degrade, so breakthrough tends to rise. This aging behavior is why generators carry both a calendar expiration and a cumulative-elution-volume expiration.⁵¹⁰

What "breakthrough" testing actually measures

The breakthrough test quantifies how much Sr-82 and Sr-85 appear in the eluate relative to the Rb-82 activity delivered. Because Rb-82 has a 75-second half-life, an eluted sample is essentially free of Rb-82 within about 10–15 minutes (ten half-lives), after which the residual measurable activity is strontium and its regrowing Rb-82 daughter. The test therefore elutes a defined volume, lets the Rb-82 decay, measures the long-lived residual activity in a dose calibrator, resolves it into Sr-82 and Sr-85, and expresses each as a ratio to the Rb-82 activity at calibration.⁴⁵

The two FDA-approved generators implement this with different elution schemes, so QC procedures are system-specific. For the analogous test on other column generators, compare Ge-68/Ga-68 generator QC and Tc-99m generator QC.

Key Technical Principles

The regulatory limits and the breakthrough ratio

Under 10 CFR 35.204, the eluate injected into a patient must satisfy two limits:¹

Sr-82: no more than 0.02 µCi Sr-82 per mCi Rb-82 (equivalently 0.02 kBq/MBq).
Sr-85: no more than 0.2 µCi Sr-85 per mCi Rb-82 (0.2 kBq/MBq).

The breakthrough ratio for each strontium isotope is simply:

R = \frac{A _{Sr}}{A _{Rb-82}}

where $A_{Sr}$ is the measured strontium activity decay-corrected to the elution/calibration time and $A_{Rb-82}$ is the Rb-82 activity eluted at calibration.

Worked example. Suppose a QC elution yields 1480 MBq (40 mCi) of Rb-82 at calibration. The maximum permitted strontium activities in that eluate are:

A_{Sr-82}^{m a x} = 0.02 \frac{μ Ci}{mCi} \times 40 mCi = 0.8 μ Ci \approx 0.030 MBq

A_{Sr-85}^{m a x} = 0.2 \frac{μ Ci}{mCi} \times 40 mCi = 8.0 μ Ci \approx 0.30 MBq

If the resolved residual measurement is 0.3 µCi Sr-82 and 4.0 µCi Sr-85, the ratios are 0.3/40 = 0.0075 µCi/mCi and 4.0/40 = 0.10 µCi/mCi — both below their limits, so the generator passes and may be used that day.¹⁴ If instead the Sr-82 measurement were 18.6 µCi (the value recorded in a documented 2019 breakthrough event), the ratio would be 18.6/40 ≈ 0.47 µCi/mCi, more than twenty times the 0.02 limit, and the eluate would be unusable and reportable.³

Why generators expire: parent decay and column life

Rb-82 availability tracks the surviving Sr-82 on the column, which decays exponentially:

A (t) = A_{0} e^{- λ t}, λ = \frac{ln 2}{T _{1/2}}

With $T_{1/2} = 25.4$ days for Sr-82, the surviving fraction after 30 days is:

\frac{A ( 30 )}{A _{0}} = e^{- \frac{l n 2}{25.4} \times 30} \approx e^{- 0.818} \approx 0.44

So a generator retains only about 44 percent of its initial Rb-82 yield after a month. That falling yield, combined with rising breakthrough risk as the column ages and accumulates elution volume, is why the labeled generators impose both a calendar expiration and a cumulative-eluate-volume limit, and why breakthrough must be checked every clinical day rather than only at receipt.⁵⁷¹⁰

Comparing the two FDA-approved generators

Feature	CardioGen-82 (Bracco)	RUBY-FILL (Jubilant DraxImage)
QC/measurement elution	~50 mL at 50 mL/min	~35 mL total at 20 mL/min
Sr-85 handling in QC	Resolve Sr-82 vs Sr-85 per label method	Total measurement with Sr-85 correction factor (~0.48)
Eluent	Additive-free 0.9% NaCl only (boxed warning)	Additive-free 0.9% NaCl only (boxed warning)
Expiration controls	Calendar and cumulative-use limits per label	Cumulative eluate ~30 L; ~60 days post-manufacture; or breakthrough limit
Sr-82 / Sr-85 limits	Per 10 CFR 35.204 (0.02 / 0.2 µCi/mCi)	Per 10 CFR 35.204 (0.02 / 0.2 µCi/mCi)

Both systems must meet the same regulatory breakthrough limits; they differ in elution volume, flow rate, and how the QC measurement resolves Sr-82 from Sr-85. Always follow the specific approved labeling for the installed generator.⁴⁵⁹ Column-chemistry studies underpinning these designs date to the earliest tin-oxide Sr/Rb generators, which demonstrated very low breakthrough over tens of liters of elution.¹⁰

Clinical Impact

Breakthrough QC protects patients from a hidden internal-dose hazard, and the consequences of skipping or mis-performing it are not hypothetical. In a 2019 event, routine QC detected Sr-82 breakthrough of 18.6 µCi where less than 1 µCi was expected; the root cause was eluting the generator with a calcium-containing solution (lactated Ringer's) instead of additive-free saline, and multiple patients had received strontium activities many times the permissible amount before the error was caught.³ Earlier breakthrough events in 2011 led to a temporary market withdrawal of one generator and its return with a boxed warning and enhanced testing instructions.⁴⁶

The clinical value of Rb-82 explains why facilities accept this QC burden. Rb-82 myocardial perfusion PET provides rest and pharmacologic-stress imaging with excellent count statistics and low per-study effective dose, and enables absolute myocardial blood flow quantification when acquired dynamically.⁹¹²¹³ Occupational dose to staff from Rb-82 production and QC is low — reported at well under a microsievert per patient in comparative work — because the tracer decays so quickly.¹¹ Guideline administered activities are on the order of 1110–1480 MBq (roughly 30–40 mCi) per acquisition, within the labeled maximum single dose.⁵¹² None of those benefits survive a breakthrough failure, which converts a vanishing tracer into a long-lived bone-seeking contaminant. For the quantitative side, see quantitative myocardial blood flow with cardiac PET.

Practical Optimization Tips

Make the daily test non-skippable

The breakthrough test is required before the first patient use of the day; build it into the morning workflow alongside dose calibrator constancy so the scanner cannot go clinical until it passes. Document who performed it, the measured values, and the pass/fail against both limits.¹²

Use only additive-free saline

Stock and label additive-free 0.9 percent sodium chloride exclusively at the generator, and physically separate any calcium-containing IV fluids from the elution supply. The most severe documented breakthrough events trace to the wrong eluent, and this is the single highest-yield error to design out.³⁶

Track breakthrough as a trend, not just a pass/fail

A generator that is passing but trending upward is telling you the column is aging. Plotting the daily Sr-82 ratio against generator age catches problems before they cross the limit and helps plan replacement around both breakthrough trend and falling Rb-82 yield.⁵¹⁰

Respect both expiration controls

Honor the calendar expiration and the cumulative-eluate-volume limit, whichever comes first. Do not extend a generator on yield grounds when volume or calendar limits are reached — those limits bound breakthrough risk, not just image quality.⁵

Verify calibrator settings for Rb-82 and residual measurement

Confirm the dose calibrator setting for Rb-82 and the residual/long-lived measurement geometry per the manufacturer's QC method, including any Sr-85 correction factor. An incorrect calibrator setting can misstate both the delivered Rb-82 and the breakthrough ratio.⁴⁵

Common pitfalls to avoid

Treating breakthrough QC as receipt-only. It is a daily test, not a one-time acceptance check.¹
Ignoring Sr-85. It has its own limit and its own dose contribution; a "pass" requires both isotopes under limit.¹
Extending a generator past a volume or calendar limit. Yield is not the governing constraint.⁵
Using the wrong eluent. Calcium-containing solutions have caused patient overexposure.³⁶
Recording only pass/fail. Trending the numeric ratio is what catches an aging column early.⁵

Regulatory Considerations

Rb-82 chloride is byproduct material for medical use, so its generator QC is governed by NRC (or Agreement State) medical-use regulation, layered on top of FDA-approved product labeling. The requirements interlock:

10 CFR 35.204 sets the permissible Sr-82 and Sr-85 concentrations (0.02 and 0.2 µCi per mCi Rb-82), requires measurement before the first patient use of the day, prohibits administering eluate that exceeds the limits, and requires reporting a measurement that exceeds the limits.¹
10 CFR 35.2204 requires the licensee to keep a record of each strontium concentration measurement, including the result, the date and time, and the individual who performed it, retained as specified in the rule.²
FDA-approved labeling for CardioGen-82 and RUBY-FILL specifies the elution method, the additive-free-saline requirement (boxed warning), alert limits that trigger additional testing, and calendar and cumulative-volume expiration controls. The labeling and the NRC rule must both be satisfied.⁴⁵
NRC advisories. Information Notice 2019-11 documents a severe breakthrough event and its root cause, reinforcing the additive-free-saline requirement and daily testing discipline; it is guidance, not a new rule, but it reflects how the agency views these failures.³⁶

Jurisdiction. Because Rb-82 is byproduct material, medical use is licensed by the NRC or by an Agreement State radiation-control program. Among the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that administer their own equivalent medical-use rules, while Washington DC and Delaware are regulated directly by the NRC. A facility must confirm which authority issues its license and follow that authority's version of the Part 35 requirements. The generator QC program should be integrated with the radiation safety officer's procedures, dose calibrator QC, and authorized-user oversight; see dose calibrator quality control and cardiac SPECT MPI quality control for the surrounding program.¹²

Frequently Asked Questions (FAQs)

What is Rb-82 generator quality control?

It is the routine testing and technique control that keeps a strontium-82/rubidium-82 generator producing safe, accurate rubidium-82 chloride for cardiac PET. Its central element is the daily strontium-breakthrough test, which measures how much of the long-lived parent Sr-82 and the contaminant Sr-85 have entered the eluate, alongside elution technique, dose calibration, and recordkeeping.

What are the Sr-82 and Sr-85 breakthrough limits?

Under 10 CFR 35.204, a Rb-82 chloride injection must contain no more than 0.02 microcurie of Sr-82 per millicurie of Rb-82 and no more than 0.2 microcurie of Sr-85 per millicurie of Rb-82. Eluate exceeding either limit must not be administered, and a measurement exceeding the limits must be reported.

How often must strontium breakthrough be measured?

10 CFR 35.204 requires measuring the Sr-82 and Sr-85 concentration before the first patient use of each day the generator is used. The approved generator labeling also requires additional testing once an alert limit is reached, and each test record must be retained as required by 10 CFR 35.2204.

Why does strontium breakthrough happen?

The generator holds Sr-82 on a column while allowing its short-lived daughter Rb-82 to be eluted. Column degradation, excessive cumulative elution, age, or the wrong eluent can let strontium wash off with the rubidium. A documented cause of severe breakthrough is eluting with a calcium-containing solution such as lactated Ringer's instead of additive-free 0.9 percent sodium chloride.

What eluent should be used for a Rb-82 generator?

Only additive-free 0.9 percent sodium chloride injection USP. Calcium-containing eluents such as lactated Ringer's have caused large strontium breakthrough and patient overexposure, and the FDA moved the additive-free-saline requirement to the top of both approved generator package inserts after those events.

What happens if breakthrough exceeds the limit?

The eluate must not be administered, generator use stops pending investigation, the measurement is recorded, and the exceedance is reported to the NRC or Agreement State as required. Follow the manufacturer's instructions, involve the radiation safety officer and authorized user, and determine root cause before resuming clinical use.

Why is Rb-82 useful for cardiac PET despite this QC burden?

Rb-82 is a potassium analog taken up by viable myocardium, and its 75-second half-life allows rapid rest and stress perfusion imaging without an on-site cyclotron. The generator makes high-throughput PET myocardial perfusion imaging practical, but its long-lived parent is exactly why disciplined breakthrough QC is non-negotiable.

Key Takeaways

The daily strontium-breakthrough test is the core of Rb-82 generator QC. It must be done before the first patient use of the day.¹
The limits are 0.02 µCi Sr-82/mCi Rb-82 and 0.2 µCi Sr-85/mCi Rb-82. Both isotopes must be under limit for a pass.¹
Use only additive-free 0.9 percent saline. Calcium-containing eluents have caused severe breakthrough and patient overexposure.³⁶
Generators expire on calendar and cumulative volume. Falling Rb-82 yield and rising breakthrough risk both track column aging.⁵¹⁰
Trend the numeric ratio. A rising-but-passing Sr-82 ratio warns of column degradation before the limit is crossed.⁵
QC is byproduct-material compliance. 10 CFR 35.204 and 35.2204, plus FDA labeling, all apply and must be documented.¹²⁴

Conclusion

The Sr-82/Rb-82 generator is what makes cardiac PET myocardial perfusion imaging practical without a cyclotron, but its long-lived parent turns a routine daily test into a genuine patient-safety control. Rb-82 generator QC — breakthrough testing before the first patient each day, correct additive-free-saline elution, disciplined calibration, expiration control, and complete records — is the difference between a 75-second tracer that disappears and a bone-seeking contaminant that does not. The documented breakthrough incidents are a reminder that the physics is unforgiving and the procedure is not optional. A program that treats the breakthrough test as a hard gate, trends its numbers, and controls its eluent will keep both patients and its license protected.¹³⁵

How DRPS Can Help

Diagnostic Radiation Physics Services (DRPS) supports cardiac PET and nuclear medicine facilities with Rb-82 generator QC program design, breakthrough-testing procedures and trending, dose calibrator QC, radiation safety officer support, authorized-user and license coordination, and NRC or Agreement State compliance reviews performed by board-certified medical physicists. DRPS serves facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A strong generator QC program is not just about passing inspection. It is about making sure the tracer you inject is the one that disappears in minutes — and nothing else.

Related Resources

References

U.S. Nuclear Regulatory Commission. 10 CFR 35.204: Permissible molybdenum-99, strontium-82, and strontium-85 concentrations. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR 35.2204: Records of molybdenum-99, strontium-82, and strontium-85 concentrations. ecfr.gov
U.S. Nuclear Regulatory Commission. Information Notice 2019-11: Strontium-82/Rubidium-82 Generator Breakthrough. 2019. ADAMS ML19281A220. nrc.gov
U.S. Food and Drug Administration. CardioGen-82 (rubidium Rb 82 generator) prescribing information. NDA 019414. accessdata.fda.gov
U.S. Food and Drug Administration. RUBY-FILL (rubidium Rb 82 generator) prescribing information. NDA 202153. accessdata.fda.gov
U.S. Food and Drug Administration. FDA reminds imaging facilities to follow safety procedures for rubidium-82 generators used in PET imaging. Drug Safety Communication. fda.gov
International Commission on Radiological Protection. ICRP Publication 107: Nuclear Decay Data for Dosimetric Calculations. Ann ICRP. 2008;38(3). icrp.org
Alvarez-Diez TM, deKemp R, Beanlands R, Vincent J. Manufacture of strontium-82/rubidium-82 generators and quality control of rubidium-82 chloride for myocardial perfusion imaging in patients using positron emission tomography. Appl Radiat Isot. 1999;50(6):1015-1023. doi:10.1016/S0969-8043(98)00170-5. PubMed
Ahmadi A, Klein R, Lewin HC, Beanlands RSB, deKemp RA. Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systems. J Nucl Cardiol. 2020;27(5):1728-1738. doi:10.1007/s12350-020-02200-6. PubMed
Brihaye C, Guillaume M, O'Brien HA, Raets D, de Landsheere C, Rigo P. Preparation and evaluation of a hydrous tin(IV) oxide 82Sr/82Rb medical generator system for continuous elution. Int J Rad Appl Instrum A. 1987;38(3):213-217. doi:10.1016/0883-2889(87)90090-6. PubMed
Tout D, Davidson G, Hurley C, Bartley M, Arumugam P, Bradley A. Comparison of occupational radiation exposure from myocardial perfusion imaging with Rb-82 PET and Tc-99m SPECT. Nucl Med Commun. 2014;35(10):1032-1037. doi:10.1097/MNM.0000000000000160. PubMed
Lassen ML, Otaki Y, Kavanagh P, et al. Simulation of low-dose protocols for myocardial perfusion 82Rb imaging. J Nucl Med. 2021;62(8):1112-1117. doi:10.2967/jnumed.120.252429. PubMed
Mercolli L, Bregenzer C, Diemling M, et al. Internal dosimetry study of [82Rb]Cl using a long axial field-of-view PET/CT. Eur J Nucl Med Mol Imaging. 2024;51(7):1869-1875. doi:10.1007/s00259-024-06660-7. PubMed